» Articles » PMID: 17021403

Identification of Der(1;19)(q10;p10) in Five Oligodendrogliomas Suggests Mechanism of Concurrent 1p and 19q Loss

Overview
Specialties Neurology
Pathology
Date 2006 Oct 6
PMID 17021403
Citations 97
Authors
Affiliations
Soon will be listed here.
Abstract

Deletions of portions of chromosomes 1p and 19q are closely associated with the oligodendroglioma histologic phenotype. In most cases, 1p and 19q are codeleted, yet the mechanism of dual loss is unexplained. We report 5 cases (World Health Organization grade III) in which metaphase cytogenetics identified a derivative chromosome consisting of what appears to be the whole arms of 1q and 19p forming a der(1;19)(q10;p10). Metaphase fluorescent in situ hybridization (FISH) confirmed the derivative chromosome was composed of 1q and 19p material in 3 cases; in 2 cases with few metaphases, FISH confirmed 19p material on the derivative chromosome. In all cases, interphase FISH showed net loss of 1p and 19q in 77% to 92% of cells, and microsatellite studies were consistent with 1p and 19q loss. We hypothesize the following: occurrence of a balanced whole-arm translocation between chromosomes 1 and 19 forming 2 derivative chromosomes, one composed of 1q and 19p, the other of 1p and 19q. Subsequent loss of the der(1;19)(p10;q10) then results in the simultaneous 1p and 19q loss observed in oligodendroglioma with retention of the der(1;19)(q10;p10) seen in these cases.

Citing Articles

Prognostic and clinical significance of contrast enhancement in WHO grade 2 oligodendrogliomas.

Zhao X, Zhang Y, Wang Y, Ren X, Zhang X, Wan H J Neurooncol. 2025; .

PMID: 39827421 DOI: 10.1007/s11060-024-04929-3.


Connectomic insights into the impact of 1p/19q co-deletion in dominant hemisphere insular glioma patients.

Yang Z, Xue B, Song X, Yin C, Yeh F, Li G Front Neurosci. 2024; 18:1283518.

PMID: 39135733 PMC: 11317282. DOI: 10.3389/fnins.2024.1283518.


Genetic and epigenetic instability as an underlying driver of progression and aggressive behavior in IDH-mutant astrocytoma.

Richardson T, Walker J, Hambardzumyan D, Brem S, Hatanpaa K, Viapiano M Acta Neuropathol. 2024; 148(1):5.

PMID: 39012509 PMC: 11252228. DOI: 10.1007/s00401-024-02761-7.


IDH inhibition in gliomas: from preclinical models to clinical trials.

Ruda R, Horbinski C, van den Bent M, Preusser M, Soffietti R Nat Rev Neurol. 2024; 20(7):395-407.

PMID: 38760442 DOI: 10.1038/s41582-024-00967-7.


Liquid Biopsy for Glioma Using Cell-Free DNA in Cerebrospinal Fluid.

Otsuji R, Fujioka Y, Hata N, Kuga D, Hatae R, Sangatsuda Y Cancers (Basel). 2024; 16(5).

PMID: 38473369 PMC: 10930790. DOI: 10.3390/cancers16051009.